25 07, 2019

Will @Illumina succeed in buying @PacBio?

By | July 25th, 2019|Categories: Uncategorized|4 Comments

The current CMA report “Anticipated acquisition by Illumina, Inc. of Pacific Biosciences of California, Inc. Decision on relevant merger situation and substantial lessening of competition” makes for some interesting, if frustrating, reading. Interesting because of what the report says but frustrating because of the redaction […]

19 06, 2019

@Illumina moving into baseball?

By | June 19th, 2019|Categories: Uncategorized|1 Comment

OK so Illumina is not (to my knowledge) planing on sponsoring the San Diego Padres. The title of this post was inspired by a wonderful bit of mistaken transcription of the recent Goldman Sachs Healthcare conference presentation by Francis deSouza “sequencers today generate baseball”…I think […]

18 04, 2019

#CRISPR Diagnostics part 2

By | April 18th, 2019|Categories: Diagnostics Tech, Methods and applications, Uncategorized|Tags: , |0 Comments

#CRISPR diagnostics got even more exciting with two big announcements last month. Firstly, Sherlock Biosciences, has spun out from The Broad Institute and Wyss Institute commercialising the SHERLOCK and INSPECTR technologies (I’ll be covering the battle for CRISPR Dx dominance in this post). Secondly, researchers at […]

21 09, 2018

Cell line variability – what will you do?

By | September 21st, 2018|Categories: Uncategorized|0 Comments

Last month Nature published a paper that revealed what many scientists knew or suspected. Cancer cell lines evolve very quickly due to positive clonal selection driven by cell culture conditions. And that this is likely the reason why the same cell line used in different labs […]

15 06, 2018

Illumina’s revenue in perspective

By | June 15th, 2018|Categories: Uncategorized|2 Comments

An interesting round up of the Top 10 Sequencing Companies from Genetic Engineering & Biotechnology News highlights the dominance of Illumina on the life-sciences (genomics) industry. Illumina’s $2.752 billion in 2017 is almost double the combined revenue of the other 9 companies ($1.445 billion). With giants […]

15 05, 2018

Ex vivo perfusion for donor organs: a BBC Tomorrow’s World special

By | May 15th, 2018|Categories: I am not a clinician, Other stuff, Uncategorized, Videos|0 Comments

Last night I watched in amazement as a beating heart was brought into the UK for transplant surgery – the heart was kept alive in the OCS HEART system. The BBC program Heart Transplant: A Chance to Live is outstanding TV and if you can […]

5 01, 2018

Cut&Run-Seq – an alternative to ChIP?

By | January 5th, 2018|Categories: Uncategorized|2 Comments

There’s a great paper from Pete Skene, postdoc 2011-2017 in the Henikoff lab, on eLife: An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. The paper describes a novel method that performs as well as ChIP-Seq, but with lower background and false-positives. ChIP-seq is […]

16 10, 2017

WGS of HPV reveals the finer details of HPV genetic variation

By | October 16th, 2017|Categories: Methods and applications, Next-generation sequencing, Uncategorized|0 Comments

Because HPV has such a small  and relatively simple genome (8,000 bp encoding 8 genes) it is possible to screen for genetic variation that may underly carcinogenesis. A team from the National Cancer Institute (NCI) has just published the sequencing of over 5,570 human cell and tissue samples – […]

5 10, 2017

Posting Enseqlopedia content to LinkedIN

By | October 5th, 2017|Categories: Uncategorized|0 Comments

Hopefully this post is going to pop up as if by magic to all my LinkedIn contacts. This is something I’ve been meaning to do for ages and finally had a go. Thanks to the people at WPBeginner for writing this “how to guide” to make […]

Load More Posts